Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9962450 Method of treating heart failure with modified relaxin polypeptides

Patent 9962450 was granted and assigned to Ambrx on May, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ambrx

Current Assignee

Ambrx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

99624500

Patent Inventor Names

Lorraine Sullivan0

Vadim Kraynov0

Amha Hewet0

Jason Pinkstaff0

Kristine De Dios0

Nick Knudsen0

Date of Patent

May 8, 2018

Patent Application Number

152392770

Date Filed

August 17, 2016

Patent Citations Received

‌

US Patent 11786578 Modified relaxin polypeptides and their uses

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

Modified relaxin polypeptides and their uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9962450 Method of treating heart failure with modified relaxin polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API